ENTITY
stringlengths 8
8
| DEFINITION
stringlengths 3
8.47k
⌀ | ALIASES
stringlengths 2
13.6k
⌀ | NAME
stringlengths 2
1.98k
|
|---|---|---|---|
C0006746 | structural protein which serves to crosslink actin chains and thus stabilize microfilaments. | caldesmon|Caldesmon | Caldesmon |
C0001478 | null | Actomyosin ATPase|actomyosin ATPase|Adenosinetriphosphatase, Actomyosin|ATPase, Actomyosin | Actomyosin Adenosinetriphosphatase |
C0041197 | A protein found in the thin filaments of muscle fibers. It inhibits contraction of the muscle unless its position is modified by TROPONIN. | Tropomyosin|Tropomyosin (substance)|tropomyosin|Tropomyosins | Tropomyosin |
C0052199 | A 34-kDa glycosylated protein. A major and most common isoform of apolipoprotein E. Therefore, it is also known as apolipoprotein E (ApoE). In human, Apo E3 is a 299-amino acid protein with a cysteine at the 112 and an arginine at the 158 position. It is involved with the transport of TRIGLYCERIDES; PHOSPHOLIPIDS; CHOLESTEROL; and CHOLESTERYL ESTERS in and out of the cells. | Apo E3|Apo E 3|APOE epsilon 3|APOE-epsilon3|Apo E-3|APOE-epsilon 3|Apolipoprotein E-epsilon3|APOE epsilon3|Apolipoprotein E epsilon3|Apolipoprotein E3|Apolipoprotein E-3|Apolipoprotein E3 (substance)|Apolipoprotein E 3|Isoapolipoprotein E3|ApoE3 | Apolipoprotein E3 |
C0034821 | Receptors on the plasma membrane of nonhepatic cells that specifically bind LDL. The receptors are localized in specialized regions called coated pits. Hypercholesteremia is caused by an allelic genetic defect of three types: 1, receptors do not bind to LDL; 2, there is reduced binding of LDL; and 3, there is normal binding but no internalization of LDL. In consequence, entry of cholesterol esters into the cell is impaired and the intracellular feedback by cholesterol on 3-hydroxy-3-methylglutaryl CoA reductase is lacking. | LDLR|Low density lipoprotein (LDL) receptor|Lipoprotein LDL Receptors|LDL Receptor|ldl receptor|low density lipoprotein receptor|ldlr|Receptor, LDL|Receptors, Lipoprotein LDL|Receptors, Low Density Lipoprotein|LDL Receptors|LDL receptor site|Low density lipoprotein receptor (substance)|Receptors, Lipoprotein, LDL|LDL Receptors, Lipoprotein|ldl receptors|Low Density Lipoprotein Receptor|Low density lipoprotein receptor|Low Density Lipoprotein Receptors|LDL receptor|Receptors, LDL | Low Density Lipoprotein Receptor |
C0052348 | null | null | arginyl adenylate |
C0052348 | null | null | arginyl adenylate |
C0035565 | A carboxy-lyase that plays a key role in photosynthetic carbon assimilation in the CALVIN-BENSON CYCLE by catalyzing the formation of 3-phosphoglycerate from ribulose 1,5-biphosphate and CARBON DIOXIDE. It can also utilize OXYGEN as a substrate to catalyze the synthesis of 2-phosphoglycolate and 3-phosphoglycerate in a process referred to as photorespiration. | Ribulose-1,5-Biphosphate Carboxylase-Oxygenase|Ribulose Bisphosphate Carboxylase|Ribulose Biphosphate Carboxylase-Oxygenase|Ribulosebiphosphate Carboxylase|Ribulose 1,5 Biphosphate Carboxylase|Carboxydismutase|Ribulose-bisphosphate carboxylase (substance)|Carboxylase-Oxygenase, 1,5-Biphosphate|Carboxylase, Ribulose-1,5-Biphosphate|Ribulosebisphosphate carboxylase/oxygenase|Ribulose 1,5 Biphosphate Carboxylase Oxygenase|Ribulose-Bisphosphate Carboxylase|Ribulose-bisphosphate carboxylase|Carboxylase, Ribulose-Bisphosphate|1,5 Biphosphate Carboxylase Oxygenase|Rubisco|Carboxylase-Oxygenase, Ribulose-1,5-Biphosphate|Diphosphate Carboxylase, Ribulose|Carboxylase, Ribulosebiphosphate|Carboxylase-Oxygenase, Ribulose Biphosphate|Ribulose Diphosphate Carboxylase|1,5-Biphosphate Carboxylase-Oxygenase|rubisco|Carboxylase, Ribulose Diphosphate|Ribulose Biphosphate Carboxylase Oxygenase|Carboxylase, Ribulose Bisphosphate|3-Phospho-D-glycerate carboxy-lyase (dimerizing)|Ribulose-1,5-Biphosphate Carboxylase|Ribulose Biphosphate Carboxylase|Biphosphate Carboxylase-Oxygenase, Ribulose | Ribulose-Bisphosphate Carboxylase |
C0242612 | An amino acid-specifying codon that has been converted to a stop codon (CODON, TERMINATOR) by mutation. Its occurance is abnormal causing premature termination of protein translation and results in production of truncated and non-functional proteins. A nonsense mutation is one that converts an amino acid-specific codon to a stop codon. | Codons, Nonsense|Nonsense Codon|Premature Stop Codons|Codons, Premature Termination|Termination Codon, Premature|Nonsense Codons|Stop Codon, Premature|Premature Termination Codons|Termination Codons, Premature|Premature Stop Codon|Codon, Termination, Premature|Codon, Premature Termination|Codon, Premature Stop|Stop Codons, Premature|Premature Termination Codon|Codons, Premature Stop | Codon, Nonsense |
C0009881 | Chemical substances or agents with contraceptive activity in males. Use for male contraceptive agents in general or for which there is no specific heading. | Male Contraceptive Agents|Male Contraceptives|contraceptives male|Male contraceptives|Agents, Male Contraceptive|male contraceptive|Contraceptives, Male|male contraceptives|male contraceptive agents | Contraceptive Agents, Male |
C0009881 | Chemical substances or agents with contraceptive activity in males. Use for male contraceptive agents in general or for which there is no specific heading. | Male Contraceptive Agents|Male Contraceptives|contraceptives male|Male contraceptives|Agents, Male Contraceptive|male contraceptive|Contraceptives, Male|male contraceptives|male contraceptive agents | Contraceptive Agents, Male |
C0598309 | null | genotoxicity | genotoxicity |
C0027567 | Denotes a person with ancestral origins are in any of the countries of Africa. | African Ancestry|Negroid Races|African Descent|Race, Negroid|Negroid|AFRICAN|African race (racial group)|African|Negroid Race|African race|Races, Negroid|Black | African race |
C0345967 | A rare type of cancer in which malignant cells are found in the sac lining the chest or abdomen. Exposure to airborne asbestos particles increases one's risk of developing malignant mesothelioma. | Malignant Mesothelial Neoplasm|Malignant Neoplasm of the Mesothelium|MESOM|MESOTHELIOMA, MALIGNANT|Malignant Mesothelial Tumor|Malignant Neoplasm of Mesothelium|Malignant Tumor of Mesothelium|Mesothelioma (malignant, clinical disorder)|Malignant mesothelioma|Malignant Mesothelioma|Mesothelioma|Mesothelioma (malignant, clinical disorder) (disorder)|Mesothelioma, malignant (morphologic abnormality)|Malignant Tumor of the Mesothelium|Cancer, mesothelioma|mesothelioma, malignant|Mesothelioma, Malignant|Mesothelioma, malignant|malignant mesothelioma | Malignant mesothelioma |
C0032227 | Presence of fluid in the pleural cavity resulting from excessive transudation or exudation from the pleural surfaces. It is a sign of disease and not a diagnosis in itself. | pleural effusion|Pleural effusion, NOS|Pleural effusion (disorder)|Pleural effusion NOS|Fluid around lungs|Unspecified pleural effusion|Effusions, Pleural|pleural effusions|Effusion, Pleural|EFFUSION PLEURAL|Thoracic effusion|pleural cavity effusion|Pleural Effusions|Pleural effusion|PLEURAL EFFUSION|Pleural Effusion|Pleural effusions | Pleural effusion disorder |
C0006279 | Washing liquid obtained from irrigation of the lung, including the BRONCHI and the PULMONARY ALVEOLI. It is generally used to assess biochemical, inflammatory, or infection status of the lung. | Bronchoalveolar lavage fluid sample|Pulmonary Lavage Fluids|Lavage Fluids, Pulmonary|Lung Lavage Fluid|Bronchoalveolar lavage fluid sample (specimen)|Bronchoalveolar Lavage Fluids|Bronchial Lavage Fluids|Lavage Fluids, Bronchial|alveolar lavage fluid|bronchial lavage fluid|Lavage Fluids, Lung|Fluid, Bronchial Lavage|Lavage Fluids, Alveolar|FLUID, BRONCHOALVEOLAR LAVAGE|Lavage Fluids, Bronchoalveolar|Lavage Fluid, Alveolar|Pulmonary Lavage Fluid|Lavage Fluid, Pulmonary|lung lavage fluid|Bronchial Lavage Fluid|Alveolar Lavage Fluids|Bronchoalveolar lavage fluid|Lung Lavage Fluids|Lavage Fluid, Bronchial|BALF - Bronchoalveolar lavage fluid|Lavage Fluid, Lung|Lavage Fluid, Bronchoalveolar|Bronchial Lavage|Bronchial Alveolar Lavage Fluid|Bronchoalveolar Lavage Fluid|Alveolar Lavage Fluid | Bronchoalveolar Lavage Fluid |
C0214743 | A cytokine synthesized by T-LYMPHOCYTES that produces proliferation, immunoglobulin isotype switching, and immunoglobulin production by immature B-LYMPHOCYTES. It appears to play a role in regulating inflammatory and immune responses. | Interleukin-13|il-13|IL13|Interleukin 13|IL 13|il13|IL-13|interleukin 13|interleukin-13|Interleukin 13 (substance) | Interleukin-13 |
C1336358 | Stage IVA includes: (T4a, N0, M0); (T4a, N1, M0); (T1, N2, M0); (T2, N2, M0); (T3, N2, M0); (T4a, N2, M0); T4a: Maxillary sinus: Moderately advanced local disease. Tumor invades anterior orbital contents, skin of cheek, pterygoid plates, infratemporal fossa, cribriform plate, sphenoid or frontal sinuses. Ethmoid sinus: Moderately advanced local disease. Tumor invades any of the following: anterior orbital contents, skin of nose or cheek, minimal extension to anterior cranial fossa, pterygoid plates, sphenoid or frontal sinuses. T1: Maxillary sinus: Tumor limited to the maxillary sinus mucosa with no erosion or destruction of bone. Ethmoid sinus: Tumor restricted to any one subsite, with or without bony invasion. T2: Maxillary sinus: Tumor causing bone erosion or destruction including extension into the hard palate and/or middle nasal meatus, except extension to posterior wall of maxillary sinus and pterygoid plates. Ethmoid sinus: Tumor invading two subsites in a single region or extending to involve an adjacent region within the nasoethmoidal complex, with or without bony invasion. T3: Maxillary sinus: Tumor invading any of the following: bone of the posterior wall of maxillary sinus, subcutaneous tissues, floor or medial wall of orbit, pterygoid fossa, or ethmoid sinuses. Ethmoid sinus: Tumor invading the medial wall or floor of the orbit, maxillary sinus, palate, or cribriform plate. N0: No regional lymph node metastasis. N1: Metastasis in a single ipsilateral lymph node, 3 cm or less in greatest dimension. N2: Metastasis in a single ipsilateral lymph node, more than 3 cm but not more than 6 cm in greatest dimension, or in multiple ipsilateral lymph nodes, none more than 6 cm in greatest dimension, or in bilateral or contralateral lymph nodes, none more than 6 cm in greatest dimension. M0: No distant metastasis. (AJCC 7th ed.) | Stage IVA Paranasal Sinus Cancer|Paranasal Sinus Cancer Stage IVA|Stage IVA Paranasal Sinus Carcinoma|Stage IVA Carcinoma of the Paranasal Sinus|Stage IVA Carcinoma of the Accessory Sinus|Stage IVA Carcinoma of Paranasal Sinus|Stage IVA Accessory Sinus Carcinoma|Stage IVA Carcinoma of Accessory Sinus | Stage IVA Paranasal Sinus Cancer AJCC v7 |
C1336358 | Stage IVA includes: (T4a, N0, M0); (T4a, N1, M0); (T1, N2, M0); (T2, N2, M0); (T3, N2, M0); (T4a, N2, M0); T4a: Maxillary sinus: Moderately advanced local disease. Tumor invades anterior orbital contents, skin of cheek, pterygoid plates, infratemporal fossa, cribriform plate, sphenoid or frontal sinuses. Ethmoid sinus: Moderately advanced local disease. Tumor invades any of the following: anterior orbital contents, skin of nose or cheek, minimal extension to anterior cranial fossa, pterygoid plates, sphenoid or frontal sinuses. T1: Maxillary sinus: Tumor limited to the maxillary sinus mucosa with no erosion or destruction of bone. Ethmoid sinus: Tumor restricted to any one subsite, with or without bony invasion. T2: Maxillary sinus: Tumor causing bone erosion or destruction including extension into the hard palate and/or middle nasal meatus, except extension to posterior wall of maxillary sinus and pterygoid plates. Ethmoid sinus: Tumor invading two subsites in a single region or extending to involve an adjacent region within the nasoethmoidal complex, with or without bony invasion. T3: Maxillary sinus: Tumor invading any of the following: bone of the posterior wall of maxillary sinus, subcutaneous tissues, floor or medial wall of orbit, pterygoid fossa, or ethmoid sinuses. Ethmoid sinus: Tumor invading the medial wall or floor of the orbit, maxillary sinus, palate, or cribriform plate. N0: No regional lymph node metastasis. N1: Metastasis in a single ipsilateral lymph node, 3 cm or less in greatest dimension. N2: Metastasis in a single ipsilateral lymph node, more than 3 cm but not more than 6 cm in greatest dimension, or in multiple ipsilateral lymph nodes, none more than 6 cm in greatest dimension, or in bilateral or contralateral lymph nodes, none more than 6 cm in greatest dimension. M0: No distant metastasis. (AJCC 7th ed.) | Stage IVA Paranasal Sinus Cancer|Paranasal Sinus Cancer Stage IVA|Stage IVA Paranasal Sinus Carcinoma|Stage IVA Carcinoma of the Paranasal Sinus|Stage IVA Carcinoma of the Accessory Sinus|Stage IVA Carcinoma of Paranasal Sinus|Stage IVA Accessory Sinus Carcinoma|Stage IVA Carcinoma of Accessory Sinus | Stage IVA Paranasal Sinus Cancer AJCC v7 |
C1306036 | The volume of gas an individual can forcible exhale from the lungs in one breath. | Forced Expiratory Volume|FEV|forced expiratory volume | Forced expiratory volume procedure |
C0221052 | null | Chronic berylliosis|Chronic beryllium poisoning|BERYLLIUM DISEASE, CHRONIC|Chronic beryllium lung|Chronic beryllium disease|Chronic berylliosis (disorder)|Beryllium granuloma|Chronic beryllium lung disease|BERYLLIOSIS, CHRONIC|Berylliosis, chronic | Chronic berylliosis |
C0024219 | The examination of the lymph nodes and lymphatic vessels following the injection of a radiopaque substance. | Lymphangiography, NOS|lymphangiogram|lymphangiography|Lymphangiogram|lymphography|Lymphangiogram (procedure)|Contrast radiology of lymphatic tissue|Lymphogram|lymphangiography procedure|Lymphangiographies|Lymphography|lymphogram|Lymphangiogram, NOS|Lymphatic system contrast procedure|Lymphangiography | Lymphangiography |
C0553534 | Having to do with the heart and lungs. | heart and lung|heart lungs|cardiopulmonary|Cardio-pulmonary|cardio pulmonary|heart lung|cardio-pulmonary|Heart and lung|lung heart|Cardiopulmonary|hearts lungs | Cardiopulmonary |
C0041290 | One of several skin tests to determine past or present tuberculosis infection. A purified protein derivative of the tubercle bacilli, called tuberculin, is introduced into the skin by scratch, puncture, or interdermal injection. | TST, NOS|skin testing tuberculin|tuberculosis skin test|TST|Tests, Tuberculin|ppd (purified protein derivative of tuberculin)|Delayed hypersensitivity skin test for tuberculin purified protein derivative|tuberculin skin test|test tuberculin|Tuberculin Tests|Tuberculin Skin Test|skin tests tuberculin|Tuberculin Test|testing tuberculin|Tuberculin test|Intradermal skin test for tuberculosis|skin tuberculosis test|skin test tuberculosis|Delayed hypersensitivity skin test for tuberculin purified protein derivative (procedure)|Test, Tuberculin|tuberculin tests|skin test tuberculin|tuberculin test|Delayed hypersensitivity skin test for tuberculin PPD|skin testing tuberculosis | Tuberculin Test |
C0430561 | A test for sensitivity to allergens. A solution containing a suspected allergy-causing substance is placed on the skin and then the skin is pricked or scratched to allow the allergen to enter the skin. If the skin develops a red, raised wheal it usually means that the person is allergic to that allergen. | Prick test (procedure)|prick skin test|Prick test|prick skin tests|prick test|Skin prick test|Prick test, NOS|epicutaneous test|prick testing|Allergy Skin Prick Test|prick skin testing|Skin Prick Test|SPT|skin prick test | Skin prick test |
C0239059 | null | cigarettes smoked|Cigarette smoke (substance)|Cigarette smoke|cigarettes smoking substances|smoke cigarette|cigarettes smoke|cigarette smoking|cigarette smoke|cigarettes smoking | Cigarette smoke (substance) |
C1326207 | A form of programmed cell death that is accompanied by the formation of autophagosomes. Autophagic cell death is characterized by lack of chromatin condensation and massive vacuolization of the cytoplasm, with little or no uptake by phagocytic cells. [GOC:autophagy, GOC:mah, GOC:mtg_apoptosis, PMID:18846107, PMID:23347517] | Autophagic Programmed Cell Death|autophagic death|non-apoptotic programmed cell death|programmed cell death by macroautophagy|Autophagy-Dependent Cell Death|Autophagy Dependent Cell Death|programmed cell death by autophagy|Cell Deaths, Autophagic|type II programmed cell death|Cell Death, Autophagic|Death, Autophagy-Dependent Cell|Death, Autophagic Cell|Cell Deaths, Autophagy-Dependent|Programmed Cell Death, Type II|Cell Death, Autophagy-Dependent|Autophagic Cell Deaths|Deaths, Autophagic Cell|Autophagy-Dependent Cell Deaths|autophagic cell death|Deaths, Autophagy-Dependent Cell | Autophagic Cell Death |
C1150604 | Catalysis of the concomitant phosphorylation of threonine (T) and tyrosine (Y) residues in a Thr-Glu-Tyr (TEY) thiolester sequence in a MAP kinase (MAPK) substrate. [ISBN:0198547684] | MAP2K|STK27|mitogen-activated protein kinase kinase activity|MAPKK activity|MAP kinase kinase activity|MAPKK|MKK6|MEK2|MAPK activator activity|ERK activator kinase activity|MKK7|MKK2|MAPKK1|ATP:protein phosphotransferase (MAPKKK-activated) activity|MKK4|MKK|MEK1 | MAP kinase kinase activity |
C0150094 | Sample in which the units are chosen on a strict "first come - first chosen" basis. All individuals who are eligible should be included as they are seen. | null | CONSECUTIVE SAMPLE |
C0027883 | Neurons which conduct NERVE IMPULSES to the CENTRAL NERVOUS SYSTEM. | afferent neurons|Sensory neuron|Neurons, Afferent|afferent neuron|sensory neurons|Afferent Neurons|Sensory Neurons|Neuron, Afferent|Sensory Cell Afferent Neuron|Afferent neuron|Sensory Neuron|Afferent Neuron|sensory neuron | Afferent neuron |
C0389549 | null | H-Sema A(V) | semaphorin A(V) |
C0389549 | null | H-Sema A(V) | semaphorin A(V) |
C0872383 | null | GRK|G protein-coupled receptor kinase (GRK)|grk | G protein-coupled receptor kinase (GRK) |
C1160439 | The establishment, maintenance and elaboration of an axis in the oocyte. An example of this is found in Drosophila melanogaster. [GOC:mtg_sensu, ISBN:0879694238] | oocyte axis determination | oocyte axis specification |
C0037864 | The process of germ cell development in the male from the primordial germ cells, through SPERMATOGONIA; SPERMATOCYTES; SPERMATIDS; to the mature haploid SPERMATOZOA. | spermatogenesis|spermatogeny|Spermatogenesis, function|Spermatogenesis, function (observable entity)|Spermatogenesis|generation of spermatozoa | Spermatogenesis |
C1160389 | The process whose specific outcome is the progression of the lung over time, from its formation to the mature structure. In all air-breathing vertebrates the lungs are developed from the ventral wall of the oesophagus as a pouch which divides into two sacs. In amphibians and many reptiles the lungs retain very nearly this primitive sac-like character, but in the higher forms the connection with the esophagus becomes elongated into the windpipe and the inner walls of the sacs become more and more divided, until, in the mammals, the air spaces become minutely divided into tubes ending in small air cells, in the walls of which the blood circulates in a fine network of capillaries. In mammals the lungs are more or less divided into lobes, and each lung occupies a separate cavity in the thorax. [GOC:jid, UBERON:0002048] | development lung|lung development|development lungs | Lung Development |
C0754091 | A GLYCOINOSITOL PHOSPHOLIPID MEMBRANE ANCHOR containing ephrin found in variety of adult tissue such as KIDNEY; LUNG; COLON and OVARY. During embryonic development, ephrin-A4 is expressed in the HIPPOCAMPUS and CEREBRAL CORTEX. It binds preferentially to ephA receptors (EPH FAMILY RECEPTORS) with the exception of the EPHA1 RECEPTOR. | Epl4 Protein|LERK 4 Protein|LERK-4 Protein|EPLG4|Ephrin-A4|LERK-4|Ephrin A4 | Ephrin-A4 |
C0023760 | Diseases involving the LIP. | disorder lips|disorders lip|Disease of lips, NOS|lip diseases|Lip Disease|Disorder of lip (disorder)|diseases of lips|lips disease|lips diseases|DISEASES OF THE LIPS|diseases of the lips|Lip Disorder|lip disease|disorders lips|Diseases of lips|Disease of lip|Disease, Lip|Disorder of lip|Diseases, Lip | Lip Diseases |
C1167080 | A structure found in the nucleolus, which contains nearly completed preribosomal particles destined for the cytoplasm. [PMID:10754561] | null | granular component |
C0028608 | null | Proteins, Nucleolar | Nucleolar Proteins |
C1156152 | Any process involved in the conversion of a primary ribosomal RNA (rRNA) transcript into one or more mature rRNA molecules. [GOC:curators] | null | rRNA processing |
C0062776 | Enzymes that catalyze the transfer of methyl groups to LYSINE or ARGININE residues of HISTONES, especially histone H3 and histone H4 proteins. They play a critical role in EPIGENETIC PROCESSES. | Methyltransferase, Histone|Histone Methyltransferase|Methylase, Histone|Histone Methylase|Methyltransferases, Histone|Histone Methyltransferases | histone methyltransferase |
C0057154 | null | daunomycin-HPMA copolymer conjugate|daunomycin-HPMA conjugate | daunomycin-N-(2-hydroxypropyl)methacrylamide copolymer conjugate |
C0063570 | null | null | inositol 1,4,5-trisphosphate 1-(2-nitrophenyl)ethyl ester |
C0063570 | null | null | inositol 1,4,5-trisphosphate 1-(2-nitrophenyl)ethyl ester |
C1323572 | Catalysis of the reaction: deoxylimonoate + H(2)O = deoxylimononate D-ring-lactone + H(+). [EC:3.1.1.46, RHEA:14997] | deoxylimonate A-ring-lactonohydrolase activity | deoxylimonate A-ring-lactonase activity |
C1323572 | Catalysis of the reaction: deoxylimonoate + H(2)O = deoxylimononate D-ring-lactone + H(+). [EC:3.1.1.46, RHEA:14997] | deoxylimonate A-ring-lactonohydrolase activity | deoxylimonate A-ring-lactonase activity |
C0836921 | The two organs situated in the throat on either side of the narrow passage from the mouth to the pharynx. They are composed of lymphoid tissues. | Oropharyngeal tonsil|tonsil|Tonsils|tonsils|TONSIL|Tonsil | Tonsil |
C0216471 | A 44 kDa mitogen-activated protein kinase kinase with specificity for MITOGEN-ACTIVATED PROTEIN KINASE 1 and MITOGEN-ACTIVATED PROTEIN KINASE 3. | MAPK ERK Kinase 2|Mitogen Activated Protein Kinase Kinase 2|MAPK-ERK Kinase 2|MAP Kinase Kinase 2|MAPK Extracellular Signal-Regulated Kinase 2|Mitogen-Activated Protein Kinase Kinase 2|MEK2 (MAPK Extracellular Signal-Regulated Kinase 2)|MAPK Extracellular Signal Regulated Kinase 2|MAPK Kinase 2|MAP2K2 Protein|Kinase Activator Kinase MEK2|MEK-2 (MAPK Extracellular Signal-Regulated Kinase 2) | MAP Kinase Kinase 2 |
C0291737 | null | PLP (139-151)|PLP 139-151|proteolipid protein 139-151 | myelin proteolipid protein (139-151) |
C1450943 | null | 3-HODB-T | 3-hydroxy-4-oxo-3,4-dihydro-5-azabenzo-1,2,3-triazene |
C1450943 | null | 3-HODB-T | 3-hydroxy-4-oxo-3,4-dihydro-5-azabenzo-1,2,3-triazene |
C1332920 | A non-neoplastic disorder that affects the cervix. Representative examples include endometriosis and cervicitis. | Cervical Non-Neoplastic Disease | Cervical Non-Neoplastic Disorder |
C1332920 | A non-neoplastic disorder that affects the cervix. Representative examples include endometriosis and cervicitis. | Cervical Non-Neoplastic Disease | Cervical Non-Neoplastic Disorder |
C0295274 | null | galectin-5 | galectin 5 |
C0026336 | representation of a process, system, or subject area that can be manipulated to demonstrate the effects that various actions will have on the process, system, or subject area; generally developed for understanding, analysis, improvement, and/or replacement of the process, system, or subject area. | Models|model | Study models |
C0855197 | A malignant tumor predominantly affecting young men and often associated with cryptorchidism. Seminoma is the most frequently seen malignant testicular germ cell tumor, followed by embryonal carcinoma and yolk sac tumor. | Malignant Germ Cell Neoplasm of Testis|Testicular cancer (excluding germ cell or trophoblastic cancer)|Malignant Testicular Germ Cell Neoplasm|Malignant Germ Cell Tumor of Testis|Testicular ca. (no germ/tropho.)|Malignant Germ Cell Neoplasm of the Testis|Malignant germ cell tumor of testis (disorder)|Testicular Germ Cell Cancer|Testicular Cancer|Malignant Testicular Germ Cell Tumor|Malignant Germ Cell Tumor of the Testis|Malignant germ cell tumor of testis|malignant testicular germ cell tumor|Malignant germ cell tumour of testis|testicular cancer | Malignant Testicular Germ Cell Tumor |
C0158687 | null | Congenital anomaly of genital organ, NOS|genital malformation|CONGENITAL ANOMALIES OF THE MALE AND FEMALE GENITAL SYSTEMS|Unspecified anomaly of genital organs|Congenital deformity of genital organ, NOS|Unspecified congenital anomaly of genital organs|Genital malformation, NOS|Congenital deformity of genital organ|Congenital deformity NOS of genital organ, NEC|Congenital anomaly NOS of genital organ, NEC|Congenital genital organ anomalies|Congenital anomalies of genital organs|congenital genital malformations|Congenital anomaly of genital organ|genital malformations|Congenital malformation of genital organs (disorder) | Congenital malformation of genital organs |
C0232989 | A pregnancy that is normal for both the mother and the fetus. | normal pregnancies|Normal pregnancy (finding)|NORMAL PREGNANCY|Pregnancy, normal|Normal Pregnancy|pregnancy normal|normal pregnancy|Normal pregnancy | Normal pregnancy |
C0404413 | null | null | Placental expression |
C1519658 | A cell from the outside layer of tissue on the blastocyte, a hollow ball of cells formed in the early development of an embryo. It attaches the blastocyte to the endometrium of the uterus and supplies nourishment to the embryo. The chorion and amnion are derived from these cells. | Trophoblastic Cell|Trophoblastic cell | Trophoblast cell |
C1336424 | Stage IV carcinoma of the major salivary glands with regional lymph nodes and/or distant metastases. | Stage IV Major Salivary Gland Cancer with Metastasis|Stage IV Carcinoma of Major Salivary Gland with Metastasis|Stage IV Carcinoma of the Major Salivary Gland with Metastasis | Stage IV Major Salivary Gland Carcinoma with Metastasis |
C1336424 | Stage IV carcinoma of the major salivary glands with regional lymph nodes and/or distant metastases. | Stage IV Major Salivary Gland Cancer with Metastasis|Stage IV Carcinoma of Major Salivary Gland with Metastasis|Stage IV Carcinoma of the Major Salivary Gland with Metastasis | Stage IV Major Salivary Gland Carcinoma with Metastasis |
C0282634 | null | Physcomitrellas|Physcomitrella | Physcomitrella |
C0006933 | The outer protein protective shell of a virus, which protects the viral nucleic acid. | Capsids|capsid|coat (nonenveloped virus)|Capsid | Capsid |
C0085363 | An order of parasitic EUKARYOTES typically having four to six flagella. True cysts are known in very few species. Trichomonadida were formerly members of the class Zoomastigophora in the old five kingdom paradigm. | ORDER TRICHOMONADIDA|Trichomonadida|Order Trichomonadida (organism)|Trichomonadidas|Order Trichomonadida | Trichomonadida |
C0007752 | The family of Old World monkeys and baboons consisting of two subfamilies: CERCOPITHECINAE and COLOBINAE. They are found in Africa and part of Asia. | Old World Monkeys|Monkey, Old World|Old World monkey|Monkeys, Old World|World Monkey, Old|FAMILY CERCOPITHECIDAE|Family Cercopithecidae|Old World Monkey|Family Cercopithecidae (organism)|Cercopithecidae|Old World monkeys|Old World monkey, NOS | Cercopithecidae |
C0085363 | An order of parasitic EUKARYOTES typically having four to six flagella. True cysts are known in very few species. Trichomonadida were formerly members of the class Zoomastigophora in the old five kingdom paradigm. | ORDER TRICHOMONADIDA|Trichomonadida|Order Trichomonadida (organism)|Trichomonadidas|Order Trichomonadida | Trichomonadida |
C1293132 | Procedure to fix a mobile or flexible structure to a rigid or inflexible structure | Anchoring|anchors|Anchoring procedure|Anchoring procedure (procedure)|anchor|anchored|anchoring | Anchoring procedure |
C0079284 | 21-Amino-acid peptides produced by vascular endothelial cells and functioning as potent vasoconstrictors. The endothelin family consists of three members, ENDOTHELIN-1; ENDOTHELIN-2; and ENDOTHELIN-3. All three peptides contain 21 amino acids, but vary in amino acid composition. The three peptides produce vasoconstrictor and pressor responses in various parts of the body. However, the quantitative profiles of the pharmacological activities are considerably different among the three isopeptides. | Endothelin|endothelins|Endothelium-Derived Vasoconstrictor Factors|Endothelins|Vasoconstrictor Factors, Endothelium-Derived|endothelin | Endothelin |
C0079284 | 21-Amino-acid peptides produced by vascular endothelial cells and functioning as potent vasoconstrictors. The endothelin family consists of three members, ENDOTHELIN-1; ENDOTHELIN-2; and ENDOTHELIN-3. All three peptides contain 21 amino acids, but vary in amino acid composition. The three peptides produce vasoconstrictor and pressor responses in various parts of the body. However, the quantitative profiles of the pharmacological activities are considerably different among the three isopeptides. | Endothelin|endothelins|Endothelium-Derived Vasoconstrictor Factors|Endothelins|Vasoconstrictor Factors, Endothelium-Derived|endothelin | Endothelin |
C0227651 | Cell found within the glomerular lobules of mammalian kidney. Mesangial cells serve as structural supports, may regulate blood flow, are phagocytic and may act as accessory cells, presenting antigen in immune responses. | Mesangial Cell, Kidney|Mesangial Cells, Kidney|Cell, Kidney Mesangial|Kidney Mesangial Cell|Cells, Kidney Mesangial|Renal Mesangial Cell|Mesangial Cell|mesangial cell|Kidney Mesangial Cells|Mesangial cell|Cell, Mesangial|Mesangial cell (cell)|Mesangial Cells, Renal|Cells, Mesangial|cells mesangial|Cell, Renal Mesangial|Renal Mesangial Cells|Glomerular mesangial cell|Mesangial cell of glomerulus|Cells, Renal Mesangial|Mesangial Cells|Mesangial Cell, Renal | Mesangial Cells, Kidney |
C1512199 | Cells found within the glomerular lobules of mammalian kidney, where they serve as structural supports, may regulate blood flow, are phagocytic and may act as accessory cells, presenting antigen in immune responses. | Glomerular Mesangial Cell|Renal Glomerulus Mesangial Cells|Mesangial Cell, Glomerular|Cells, Glomerular Mesangial|Cell, Glomerular Mesangial|Mesangial Cells, Glomerular|Glomerular Mesangial Cells | Glomerular Mesangial Cells |
C0085752 | null | adriamycin|Adriamycin|Adriamycine | Adriamycin |
C0139121 | null | SZD PSC 833|PSC833|psc 833|psc-833|PSC 833|psc833|SDZ-PSC-833|PSC-833 | SDZ PSC 833 |
C0017658 | Inflammation of the renal glomeruli (KIDNEY GLOMERULUS) that can be classified by the type of glomerular injuries including antibody deposition, complement activation, cellular proliferation, and glomerulosclerosis. These structural and functional abnormalities usually lead to HEMATURIA; PROTEINURIA; HYPERTENSION; and RENAL INSUFFICIENCY. | glomerulonephritides|Scarring, Kidney|Glomerular Nephritis|Kidney Scarring|Glomerulonephritis|glomerulonephritis|Glomerulonephritis (disorder)|Glomerulonephritis, NOS|Glomerular nephritis|Glomerulonephritis NOS|GN - Glomerulonephritis|GLOMERULONEPHRITIS|Glomerulonephritides | Glomerulonephritis |
C0021756 | A soluble substance elaborated by antigen- or mitogen-stimulated T-LYMPHOCYTES which induces DNA synthesis in naive lymphocytes. | Interleukin-2-containing product|Product containing interleukin-2 (medicinal product)|Interleukin 2|IL2 Protein|Interleukin 2 Precursor|ETAF|T Cell Stimulating Factor|il-2|Lymphocyte Mitogenic Factor|T-stimulating factor|interleukin ii|Interleukin II|INTERLEUKIN-2|T cell growth factor|Mitogenic Factor, Lymphocyte|T-Cell Stimulating Factor|Lymphocyte blastogenic factor|TSF (thymocyte stimulating factor)|co-stimulator|il2|IL2|il 2|tsf|costimulator|interleukin 2|Mitogenic Factor|TSF|T-Cell Growth Factor|Interleukin-2 (substance)|TCGF (T cell growth factor)|T Cell Growth Factor|Interleukine 2|TCGF|Thymocyte Stimulating Factor|Epidermal Thymocyte Activating Factor|IL-2|Interleukin-2|interleukin-2|Lymphocyte mitogenic factor | Interleukin-2 |
C0017649 | A family of globular proteins found in blood that does not include albumin. These proteins are insoluble in water but solubility is increased in dilute salt solutions. Globulins are grouped into four categories (alpha 1, alpha 2, beta and gamma) based on differences in electrophoretic mobility. | Globulin (substance)|Serum Globulin|Globulin, NOS|globulin|Globulins|Globulin|globulins | Globulins |
C0052055 | null | Glomerular basement membrane antibody|GBMab - Glomerular basement membrane antibody|Antibody to glomerular basement membrane|Collagen type IV antibody|anti gbm|Glomerular basement membrane antibody (substance)|antiglomerular basement membrane antibody|Anti-glomerular basement membrane antibody|GBMA - Glomerular basement membrane antibody|anti-gbm|Anti GBM antibody|GBM - Glomerular basement membrane antibody|AGBMAb - Anti-glomerular basement membrane antibody|Goodpasture's antibody|Anti glomerular basement membrane antibody|anti-GBM | Glomerular basement membrane antibody |
C0023308 | Diseases involving the CRYSTALLINE LENS. | Disorder of lens (disorder)|Lens disease|Lens Diseases|DISORDERS OF THE LENS|lens disorder|Diseases, Lens|Lens Disorder|Disease, Lens|Disorder of lens|Disorder of lens, NOS|Lens Disease | Lens Diseases |
C0023308 | Diseases involving the CRYSTALLINE LENS. | Disorder of lens (disorder)|Lens disease|Lens Diseases|DISORDERS OF THE LENS|lens disorder|Diseases, Lens|Lens Disorder|Disease, Lens|Disorder of lens|Disorder of lens, NOS|Lens Disease | Lens Diseases |
C0003250 | Antibodies produced by a single clone of cells. | MAb|Monoclonal antibodies|Monoclonal Antibody|Monoclonal protein|Monoclonal Antibody Therapy|Product containing monoclonal antibody (product)|Monoclonal Antibodies|Antibodies, Monoclonal|monoclonal antibody|Monoclonal immunoglobulin-containing product|monoclonal antibodies|Monoclonal immunoglobulin|Monoclonal antibody (substance)|Monoclonal antibody|MoAB|Monoclonal antibody-containing product | Monoclonal Antibodies |
C0027721 | A kidney disease with no or minimal histological glomerular changes on light microscopy and with no immune deposits. It is characterized by lipid accumulation in the epithelial cells of KIDNEY TUBULES and in the URINE. Patients usually show NEPHROTIC SYNDROME indicating the presence of PROTEINURIA with accompanying EDEMA. | Minimal Change Nephropathy|minimal change nephropathy|Minimal Change Nephropathies|Nephrosis, Lipoid|change glomerulonephritis minimal|MCGN - Minimal change glomerulonephritis|change disease minimal|Minimal Change Diseases|Lipid nephrosis|Glomerulopathies, Minimal Change|Lipoid Nephrosis|MCN - Minimal change nephropathy|Minimal Change Glomerulonephritis|MINIMAL CHANGE GLOMERULOPATHY|Diseases, Minimal Change|NEPHROSIS, LIPOID|Nil disease|NIL DISEASE|Minimal change glomerular disease|nephrosis lipoid|Lipoid Nephroses|Lipoid nephrosis|Minimal lesion glomerulonephritis syndrome|Nil change disease|Nephropathy, Minimal Change|Glomerulopathy, Minimal Change|FOOT PROCESS DISEASE|MCD - Minimal change disease|changes glomerulonephritis minimal|lipoid nephrosis|Nephroses, Lipoid|Disease, Minimal Change|Minimal Change Disease|Minimal change glomerulonephritis|Foot-process disease|disease nils|Nephropathies, Minimal Change|Minimal Change Glomerulopathy|Nephrosis, lipoid|Minimal change disease (disorder)|Change Diseases, Minimal|Foot process disease|Minimal change nephropathy|Idiopathic Minimal Change Nephrotic Syndrome|Epithelial-cell disease|change diseases minimal|nil disease|Minimal change disease|MINIMAL CHANGE DISEASE|minimal change disease|MINIMAL CHANGE NEPHROPATHY|Light negative glomerulonephritis | Lipoid nephrosis |
C0403396 | Nephrotic syndrome, occurring in the pediatric population, characterized by the normalization of proteinuria with the administration of corticosteroids. | SSNS - Steroid-sensitive nephrotic syndrome|Steroid-sensitive nephrotic syndrome (disorder)|Steroid-responsive nephrotic syndrome|Steroid sensitive nephrotic syndrome of childhood|Steroid sensitive nephrotic syndrome of childhood (disorder)|Steroid-Sensitive Nephrotic Syndrome|Nephrotic Syndrome of Childhood - Steroid Sensitive|Steroid-Responsive Nephrotic Syndrome | Steroid-sensitive nephrotic syndrome |
C1527446 | null | dystrobrevin | dystrobrevin |
C0071756 | null | KCASO|potassium arrest solution | potassium cardioplegic solution |
C0071756 | null | KCASO|potassium arrest solution | potassium cardioplegic solution |
C1512777 | A synapse in which an action potential in the presynaptic cell reduces the probability of an action potential occurring in the postsynaptic cell. [GOC:dph, GOC:ef] | inhibitory synapse | Inhibitory Synapse |
C0598501 | The meiotic cell cycle process where side by side pairing and physical juxtaposition of homologous chromosomes is created during meiotic prophase. Synapsis begins when the chromosome arms begin to pair from the clustered telomeres and ends when synaptonemal complex or linear element assembly is complete. [GOC:mtg_cell_cycle, PMID:22582262, PMID:23117617] | homologous chromosome pairing at meiosis|Chromosome Pairings|chromosomal synapsis|chromosome paired|Chromosomal Synapsis|chromosomal synapses|Chromosome Pairing|chromosomal pairing|Synapsis, Chromosomal|synapsis|Synapsis|chromosomal synapse | Chromosome Pairing |
C0022009 | Gated, ion-selective glycoproteins that traverse membranes. The stimulus for ION CHANNEL GATING can be due to a variety of stimuli such as LIGANDS, a TRANSMEMBRANE POTENTIAL DIFFERENCE, mechanical deformation or through INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS. | Ionic Channels|Channel, Ion|Channels, Ion|Ion Channel|ion channels|Ionic Channel|membrane channels|ion channel|Channels, Membrane|Channels, Ionic|Ion Channels|Ion channels|Channel, Membrane|Membrane Channel|Membrane Channels|ionic channel|Channel, Ionic|membrane channel | Ion Channel |
C0022009 | Gated, ion-selective glycoproteins that traverse membranes. The stimulus for ION CHANNEL GATING can be due to a variety of stimuli such as LIGANDS, a TRANSMEMBRANE POTENTIAL DIFFERENCE, mechanical deformation or through INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS. | Ionic Channels|Channel, Ion|Channels, Ion|Ion Channel|ion channels|Ionic Channel|membrane channels|ion channel|Channels, Membrane|Channels, Ionic|Ion Channels|Ion channels|Channel, Membrane|Membrane Channel|Membrane Channels|ionic channel|Channel, Ionic|membrane channel | Ion Channel |
C0536483 | null | AMPA receptor, GluR2 subunit|GluR2 receptor | glutamate receptor ionotropic, AMPA 2 |
C0002897 | null | Splenic Anemias|Anemias, Splenic|Splenic Anemia | Anemia, Splenic |
C0018767 | The ability or act of sensing and transducing ACOUSTIC STIMULATION to the CENTRAL NERVOUS SYSTEM. It is also called audition. | Hearing|auditory senses|Hearing, function|Hearing, function (observable entity)|Perception of sound|hear|Hearing, NOS|auditory sense|sound perception|hears|Auditory function|Hearing Functions|AUDITION|auditory functions|hearing|Audition, NOS|sensory perception of sound|perception of sound|hearing perception|Audition|audition|auditory function | Hearing |
C0029894 | Crystals of calcium carbonate embedded in the otolithic membrane in the maculae of the saccule and utricle in the inner ear, which comprise the otolith organs containing receptors that respond to gravity and head tilt. | otoconia|Statoconium|otocyst/otolith|Statoconias|Statoconia|otocyst|Otolith|Otoconium|otoliths|Set of otoliths|statoconia|Otoconias|Structure of otoconia (body structure)|Otoliths|Otoconia|Structure of otoconia|otolith | Structure of otoconia |
C0240188 | null | null | LIGHT STIMULATION |
C0051169 | A P450 oxidoreductase that catalyzes the hydroxylation of the terminal carbon of linear hydrocarbons such as OCTANES and FATTY ACIDS in the omega position. The enzyme may also play a role in the oxidation of a variety of structurally unrelated compounds such as XENOBIOTICS, and STEROIDS. | Omega Lauryl Hydroxylase|Alkane 1-monooxygenase|Alkane 1 Hydroxylase|Fatty Acid Omega Hydroxylase|Lauric Acid Monooxygenase|Hydroxylase, Alkane|Hydroxylase, Omega-1|Omega-Hydroxylase, Fatty Acid|Alkane 1-monooxygenase (substance)|CYP4A, Cytochrome P-450|Alkane Hydroxylase|Lauric Acid Omega hydroxylase|Omega-hydroxylase, Lauric Acid|Hydroxylase, Omega-Lauryl|P-450 4A, Cytochrome|CYP4A|Omega-1 Hydroxylase|Cytochrome P 450 IVA|Cytochrome P 450 4A|w-Hydroxylase|P-450 CYP4A, Cytochrome|Acid Omega-Hydroxylase, Fatty|Lauric Acid Hydroxylase|Lauric Acid (Omega-1)-Hydroxylase|Lauric Acid Omega-hydroxylase|Fatty acid w-hydroxylase|Alkane 1-hydroxylase|Cytochrome P 450 CYP4A|Omega-Hydroxylase, Laurate|Acid Hydroxylase, Lauric|Omega-Lauryl Hydroxylase|Cytochrome P-450 IVA|Fatty Acid Omega-Hydroxylase|Omega-Hydroxylase|Laurate Omega-Hydroxylase|Alkane 1 Monooxygenase|Alkane 1-Hydroxylase|Omega Hydroxylase|Laurate Omega Hydroxylase|Acid Omega-hydroxylase, Lauric|Omega 1 Hydroxylase|Cytochrome P-450 4A|Alkane 1-Monooxygenase|w-hydroxylase|Cytochrome P-450 CYP4A | Alkane 1-monooxygenase |
C0682694 | null | inhibitory interneuron | Inhibitory interneuron |
C0969321 | A vesicular glutamate transporter protein that is predominately expressed in the DIENCEPHALON and lower brainstem regions of the CENTRAL NERVOUS SYSTEM. | DNPI Protein|Differentiation-Associated Na-Dependent Inorganic Phosphate Cotransporter|Differentiation Associated Na Dependent Inorganic Phosphate Cotransporter|VGLUT2 Protein|Vesicular Glutamate Transport Protein 2|Vesicular Glutamate Transporter 2 | Vesicular Glutamate Transport Protein 2 |
C0441987 | A line segment forming part of the perimeter of a plane figure. | Side (qualifier value)|Side|side | Side |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.